Azelis Group NV (AZE) - Total Liabilities
Based on the latest financial reports, Azelis Group NV (AZE) has total liabilities worth €2.69 Billion EUR (≈ $3.15 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Azelis Group NV cash flow conversion to assess how effectively this company generates cash.
Azelis Group NV - Total Liabilities Trend (2018–2025)
This chart illustrates how Azelis Group NV's total liabilities have evolved over time, based on quarterly financial data. For the full company profile including market capitalisation, see AZE company net worth.
Azelis Group NV Competitors by Total Liabilities
The table below lists competitors of Azelis Group NV ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Beijing Cisri Gaona Materials Tech
SHE:300034
|
China | CN¥3.46 Billion |
|
Compagnie Financiere Tradition
SW:CFT
|
Switzerland | CHF1.24 Billion |
|
Société BIC SA
PA:BB
|
France | €1.06 Billion |
|
Hanesbrands Inc
NYSE:HBI
|
USA | $3.83 Billion |
|
Ecopro Co. Ltd
KQ:086520
|
Korea | ₩5.29 Trillion |
|
SK Bioscience Co Ltd
KO:302440
|
Korea | ₩847.96 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥1.04 Billion |
|
Guangdong Advertising Co Ltd
SHE:002400
|
China | CN¥6.04 Billion |
Liability Composition Analysis (2018–2025)
This chart breaks down Azelis Group NV's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.95 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.50 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Azelis Group NV's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Azelis Group NV (2018–2025)
The table below shows the annual total liabilities of Azelis Group NV from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €2.69 Billion ≈ $3.15 Billion |
-5.34% |
| 2024-12-31 | €2.84 Billion ≈ $3.32 Billion |
-1.83% |
| 2023-12-31 | €2.90 Billion ≈ $3.39 Billion |
+14.13% |
| 2022-12-31 | €2.54 Billion ≈ $2.97 Billion |
+46.61% |
| 2021-12-31 | €1.73 Billion ≈ $2.02 Billion |
-0.36% |
| 2020-12-31 | €1.74 Billion ≈ $2.03 Billion |
+5.53% |
| 2019-12-31 | €1.65 Billion ≈ $1.92 Billion |
+13.22% |
| 2018-12-31 | €1.45 Billion ≈ $1.70 Billion |
-- |
About Azelis Group NV
Azelis Group NV engages in the distribution of specialty chemicals and food ingredients. The company provides specialty chemical products used in the life sciences, such as personal care, home care, industrial cleaning, pharmaceuticals, healthcare, food and nutrition, animal nutrition, agricultural environmental, flavours and fragrances, and nutraceuticals solutions; and industrial chemicals indu… Read more